INMB INmune Bio Corporation Return on Gross Profit

Official company branding of INmune Bio Corporation (INMB)

The development of drugs to correct innate immunity in cancer and dementia, combined with the implementation of eco-friendly reagent disposal standards, creates long-term rent potential for INmune Bio, Inc. (INMB). The net gross margin illustrates this resilience, with the value holding at 0.00. Current progress is bolstered by a breakthrough in TNF neutralization, making the company's pipeline highly efficient for upcoming medical releases.

INmune Bio Inc (INMB) Gross Profitability: for the period 07/04/2022 - 11/19/2026

Comprehensive metric breakdowns and analytics for INmune Bio, Inc. (INMB)

- stock quotes and analyst forecast:
Fundamental valuation:INmune Bio, INMB
Signature product of INmune Bio Corporation

Gross margin measures the efficiency of covering direct production costs, demonstrating the portion of revenue available for operational development and investment. By analyzing gross margin variance, an investor assesses the financial stability of INmune Bio, Inc. (INMB) amid the development of innovative TNF neutralization methods for oncology and Alzheimer's disease therapies, where high margins would confirm the commercial potential of these scientific breakthroughs.

Direct competitors

argenx - Gross Profit Rate|Gross Profitability biontech.de|ABIVAX (ABVX) - Return on Sales by Gross Profit|Gross Margin ADMA|Gross Profit Ratio PTGX|Gross Profitability Immunovant Corp IMVT|Gross Margin Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Gross Profitability|Return on Sales by Gross Profit Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Return on Gross Profit|Aurinia Pharmaceuticals Inc. (AUPH) - Gross Margin|Return on Gross Profit BCRX|Gross Profit Margin Vera Therapeutics Inc VERA|Return on Gross Profit DNTH (Dianthus Pharma)|Return on Sales by Gross Profit Pharvaris N.V.|AbCellera Biologics Inc - Return on Gross Profit|Tourmaline Bio (TRML) - Gross Profit Margin|PGEN - Gross Profitability|Gross Profit Rate PHAR (Pharming Group NV)|NKTR: Gross Margin|Upstream Bio Corp - Gross Profit Rate|Gross Profitability Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Return on Sales by Gross Profit|Gross Margin GOSS|Return on Gross Profit KalVista Pharmaceuticals, Inc. KALV|Gross Profitability Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Gross Profit Margin|SVRA - Gross Profitability|Rigel Pharmaceuticals - Gross Profit Ratio|AnaptysBio Corp (ANAB) - Gross Profitability|ATXS - Return on Sales by Gross Profit|Gross Profitability enGene Holdings Inc.|RAPT: Gross Profit Rate|Gross Margin JBIO|Return on Gross Profit aclaristx.com ACRS|Gross Profitability Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Gross Profit Margin|Cabaletta Bio, Inc - Gross Margin|Gross Profit Margin Ventyx Biosciences|THTX (theratech.com) - Return on Gross Profit|Return on Gross Profit Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Gross Margin|Gross Profit Margin Agenus Inc. AGEN|Return on Gross Profit CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Gross Profit Rate|Gross Profitability atyrpharma.com ATYR|Gross Margin Adagene Corp ADAG|IMA - Gross Profitability|Gross Profit Rate STTK (Shattuck Labs)|EQ: Gross Margin|Connect Biopharma (CNTB) - Gross Margin|Gross Profitability Immunic|Gross Margin atarabio.com|Gross Margin IFRX|Gross Margin X4 Pharma (XFOR)|Gross Margin ACET (adicetbio.com)|Gross Margin Celularity Inc. CELU|Barinthus Biotherapeutics - Gross Margin|Kezar Life Sciences, Inc. (KZR) - Return on Gross Profit|SAB Biotherapeutics Inc. (SABS) - Gross Profitability|Return on Gross Profit Akari Therapeutics plc|Gross Profitability enlivex.com|q32bio.com (QTTB) - Return on Sales by Gross Profit|Gross Margin GOVX|Edesa Biotech, Inc. - Gross Return on Sales|iBio Inc - Return on Gross Profit|Gross Margin Carisma Therapeutics CARM|XTLB - Gross Profitability|BOLT (boltbio.com) - Gross Return on Sales|HCWB: Gross Margin|Aptevo (APVO) - Gross Margin|Gross Profitability AIM ImmunoTech|Return on Gross Profit Aditxt (ADTX)|Return on Gross Profit GRI (GRI Bio Corporation)|XORTX - Gross Return on Sales|Gross Margin HIND (Vyome Holdings Inc.)|Gross Profit Rate REVB|Indaptus - Gross Margin|SCNI (Scinai Immunotherapeutics Ltd.) - Gross Return on Sales|CALI: Gross Margin|Affimed NV - Gross Profit Rate|Gross Profitability Allakos Inc.|Gross Margin HOOKIPA Pharma|Gross Profitability IGM Biosciences, Inc. (IGMS)|ITOS - Gross Profit Margin|Gross Margin OCEA (Ocean Bio)|Gross Profit Rate TCBP|THRD - Gross Profitability